Adherence to antiretroviral therapy in patients participating in a graduated cost recovery program at an HIV care center in South India

AIDS and Behavior

Volumn 14, Issue 4, 2010, Pages 794-798

  Batavia, Ashita S ^a   Balaji, Kavitha ^b   Houle, Elizabeth ^c   Parisaboina, Sangeetha ^b   Ganesh, A K ^b   Mayer, Kenneth H ^d   Solomon, Suniti ^b  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b YRG CARE   (India)

^c JOHNS HOPKINS HOSPITAL   (United States)

^d MIRIAM HOSPITAL   (United States)

Author keywords

Adherence; Antiretroviral therapy; Costs; HIV; India

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; COST; COST OF ILLNESS; ECONOMICS; EDUCATIONAL STATUS; FEMALE; HEALTH CARE COST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCOME; INDIA; MALE; MEDICAL CARE; PATIENT COMPLIANCE; STATISTICS;

ADULT; ANTI-HIV AGENTS; CD4 LYMPHOCYTE COUNT; COST OF ILLNESS; COSTS AND COST ANALYSIS; EDUCATIONAL STATUS; FEMALE; HEALTH CARE COSTS; HIV INFECTIONS; HUMANS; INCOME; INDIA; MALE; MEDICAL ASSISTANCE; MEDICATION ADHERENCE;

EID: 77956886220     PISSN: 10907165     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10461-009-9663-6     Document Type: Article

References (39)

1. Karon JM, Fleming PL, Steketee RW, De Cock KM. HIV in the United States at the turn of the century: an epidemic in transition. Am J Public Health. 2001;91:1060-8.
2. Murphy EL, Collier AC, Kalish LA, et al. Highly active anti-retroviral therapy decreases mortality and morbidity in patients with advanced HIV disease. Ann Intern Med. 2001;135:17-26.
3. Hogg RS, Heath KV, Yip B, et al. Improved survival among HIV-infected individuals following initiation of antiretroviral therapy. JAMA. 1998;279:450-4.
4. Palella FJ, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection HIV Outpatient Study Investigators. N Engl J Med. 1998;338:853-60.
5. Powderly WG, Landay A, Lederman MM. Recovery of the immune system with antiretroviral therapy: the end of opportunism? JAMA. 1998;280:72-7.
6. Vittinghoff E, Scheer S, O'Malley P, Colfax G, Holmberg SD, Buchbinder SP. Combination antiretroviral therapy and recent declinesinAIDS incidence and mortality. JAIDS. 1999;179:717-20.
7. Sabate E, editor. Adherence to long-term therapies evidence for action. Geneva, Switzerland: World Health Organization; 2003.
8. Paterson DL, Swindells S, Mohr J, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med. 2000;133:21-30.
9. Bangsberg DR, Hecht FM, Charlesbois ED, et al. Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. AIDS. 2000;14:357-66.
10. Nieuwkerk PT, Gisolf EH, Reijers MH, Lange JM, Danner SA, Sprangers MA, et al. Long-term quality of life outcomes in three antiretroviral treatment strategies for HIV-1 infection. AIDS. 2001;15:1985-91.
11. Farmer P, Leandre F, Mukherjee JS, et al. Community-based approaches to HIV treatment in resource-poor settings. Lancet. 2001;358:404-9.
12. Lanièce I, Ciss M, Desclaux A, et al. Adherence to HAART and its principal determinants in a cohort of Senegalese adults. AIDS. 2003;17:S103-8.
13. Kumarasamy N, Venkatesh KK, Mayer KH, Freedberg K. Financial burden of health services for people with HIV/AIDS in India. Indian J Med Res. 2007;126:509-17.
14. Weidle PJ, Malamba S, Mwebaze R, et al. Assessment of a pilot antiretroviral drug therapy programme in Uganda: patients' response, survival, and drug resistance. Lancet. 2002;360:34-40.
15. Weiser S, Wolfe W, Bangsberg D, et al. Barriers to antiretroviral adherence for patients living with HIV infection and AIDS in Botswana. JAIDS. 2003;34:281-8
16. UNAIDS. UNAIDS/WHO AIDS epidemic update. 2007. Available from http://www.unaids.org/epidemic-update/. Accessed 1 Nov 2009.
17. The World Development Indicators database, World Bank. Available from: http://ddp-ext.worldbank.org/CSIDB/getCountry StatInfoXML?id=ind&format= CSIDB (2008). Accessed 1 Nov 2008.
18. Safren S, Kumarasamy N, James R, Raminani S, Solomon S, Mayer KH. ART adherence, demographic variables and CD4 outcome among HIV-positive patients on antiretroviral therapy in Chennai, India. AIDS Care. 2005;17:853-62.
19. Kumarasamy N, Safren SA, Raminani SR, et al. Barriers and facilitators to antiretroviral medication adherence among patients with HIV in Chennai, India: a qualitative study. AIDS Patient Care STDs. 2005;19:526-36.
20. Kumarasamy N, Vallabhaneni S, Cecelia AJ, et al. Reasons for modification of generic highly active antiretroviral therapeutic regimens among patients in Southern India. JAIDS. 2006;41:53-8.
21. Tchetgen E, Kaplan EH, Friedland GH. Public health consequences of screening patients for adherence to highly active antiretroviral therapy. JAIDS. 2001;26:118-29.
22. Wu AW, Ammassari A, Antinori A. Adherence to antiretroviral therapy: where are we, and where do we go from here? JAIDS. 2002;31:S95-7.
23. Yeni PG, Hammer SM, Hirsch MS, et al. Antiretroviral treatment for adult HIV infection in 2002: updated recommendations of the International AIDS Society-USA Panel. JAMA. 2002;288:222-35.
24. Sangeetha P, Sripriya P, Ganesh AK, Solomon SS, Duraisamy P. Enhancing HAART through graduated cost recovery in GFATM. In: Poster presentation at XVI international AIDS conference, abstract code: MOPE0706; 2006.
25. Byakika-Tusiime J, Oyugi JH, Tumwikirize WA, Katabira ET, Mugyenyi EN, Bangsberg DR. Adherence to HIV antiretroviral therapy in HIV? Ugandan patients purchasing therapy. Int J STD AIDS. 2005;16:38-41.
26. Crane JT, Kawuma A, Oyugi JH, et al. The price of adherence: qualitative findings from HIV positive individuals purchasing fixed-dose combination generic HIV antiretroviral therapy in Kampala, Uganda. AIDS Behav. 2006;10:437-42.
27. Gupta I, Trivedi M, Kandamuthan S. Costing of free ART programme of the government of India; 2006. Available from: http://iegindia.org/dis-111-2006.pdf. Accessed 6 Nov 2009.
28. Gupta I, Sankar D. Treatment-seeking behaviour and the willingness to pay for antiretroviral therapy of HIV positive patients in India. In: Over M, Heywood P, Gold J, Gupta I, Hira S, Marseille E, editors. HIV/AIDS treatment and prevention in India: modeling the costs and consequences. Washington, DC: World Bank; 2004.
29. Reynolds NR. Adherence to antiretroviral therapies: state of the science. Curr HIV Res. 2004;2:207-14.
30. Miller LG, Hays RD. Adherence to combination antiretroviral therapy: synthesis of the literature and clinical implications. AIDS Read. 2000;10:177-85.
31. Wagner G, Miller LG. Is the influence of social desirability on patients' self-reported adherence overrated? JAIDS. 2004;35(2): 203-4.
32. Simoni JM, Kurth AE, Pearson CR, Pantalone DW, Merrill JO, Frick PA. Self-report measures of antiretroviral adherence: a review with recommendations for HIV research and clinical management. AIDS Behav. 2006;10:227-45.
33. Ammassari A, Antinori A, Aloisi MS, et al. Depressive symptoms, neurocognitive impairment, and adherence to highly active antiretroviral therapy among HIV-infected persons. Psychoso-matics. 2004;45:394-402.
34. Chander G, Lau B, Moore RD. Hazardous alcohol use: a risk factor for non-adherence and lack of suppression in HIV infection. JAIDS. 2006;43:411-7.
35. Golin CE, Earp J, Tien HC, Stweart P, Porter C, Howie L. A 2-arm, randomized, controlled trial of a motivational interview-ing-based intervention to improve adherence to antiretroviral therapy (ART) among patients failing or initiating ART. JAIDS. 2006;42: 42-51.
36. Lucas GM, Mullen BA, McCaul ME. Adherence, drug use, and treatment failure in a methadone-clinic-based program of directly administered antiretroviral therapy. AIDS Patient Care STDs. 2001;21:564-74.
37. Nachega JB, Stein DM, Lehman DA, et al. HIV/AIDS and antiretroviral treatment knowledge, attitudes, beliefs, and practices in HIV-infected adults in Soweto, South Africa. JAIDS. 2005;38:196-201.
38. Nguyen VK, Ako CY, Niamba P, Sylla A, Tiendrebeogo I. Adherence as therapeutic citizenship: impact of the history of access to antiretroviral drugs on adherence to treatment. AIDS. 2007;21:S31-5.
39. Schönnesson LN, Williams ML, Ross MW, Diamond PM, Keel P. Three types of adherence to HIV antiretroviral therapy and their association with AIDS diagnosis, medication side-effects, beliefs about antiretroviral therapy, and beliefs about HIV disease. Int J STD AIDS. 2007;18:369-73.